MX2018001222A - Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla. - Google Patents
Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.Info
- Publication number
- MX2018001222A MX2018001222A MX2018001222A MX2018001222A MX2018001222A MX 2018001222 A MX2018001222 A MX 2018001222A MX 2018001222 A MX2018001222 A MX 2018001222A MX 2018001222 A MX2018001222 A MX 2018001222A MX 2018001222 A MX2018001222 A MX 2018001222A
- Authority
- MX
- Mexico
- Prior art keywords
- preparing
- pharmaceutical composition
- same
- storage stability
- improved storage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Se provee una composición farmacéutica que contiene un compuesto relacionado específico en una cantidad por debajo del estándar y un método para preparar la misma.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150106628A KR101787447B1 (ko) | 2015-07-28 | 2015-07-28 | 보관 안정성이 향상된 약학 조성물 및 그의 제조 방법 |
PCT/KR2016/008269 WO2017018819A1 (en) | 2015-07-28 | 2016-07-28 | Pharmaceutical composition with improved storage stability and method for preparing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018001222A true MX2018001222A (es) | 2018-04-24 |
Family
ID=57884931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018001222A MX2018001222A (es) | 2015-07-28 | 2016-07-28 | Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP3328436A4 (es) |
JP (1) | JP2018521106A (es) |
KR (1) | KR101787447B1 (es) |
CN (1) | CN106659680A (es) |
AU (1) | AU2016299547A1 (es) |
BR (1) | BR112018001719A2 (es) |
CA (1) | CA2993923A1 (es) |
HK (1) | HK1249440A1 (es) |
IL (1) | IL257181A (es) |
MX (1) | MX2018001222A (es) |
RU (1) | RU2018107054A (es) |
WO (1) | WO2017018819A1 (es) |
ZA (1) | ZA201801186B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190231689A1 (en) * | 2018-01-29 | 2019-08-01 | Samyang Biopharmaceuticals Corporation | Amphiphilic Block Copolymer Composition With Enhanced Micelle Stability |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5887201A (en) * | 2000-05-12 | 2001-11-20 | Samyang Corp | Method for the preparation of polymeric micelle via phase separation of block copolymer |
EP1448707B1 (en) * | 2001-10-18 | 2007-08-22 | Samyang Corporation | Polymeric micelle composition with improved stability |
EP1967854B8 (en) | 2007-03-06 | 2010-12-29 | Cell Therapeutics, Inc. | Method for determining the amount of conjugated taxane in polyglutamic acid-taxane conjugates |
US8853351B2 (en) * | 2007-12-31 | 2014-10-07 | Samyang Biopharmaceuticals Corporation | Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof |
KR101024742B1 (ko) * | 2007-12-31 | 2011-03-24 | 주식회사 삼양사 | 탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법 |
EP2201935B1 (en) * | 2008-12-26 | 2020-07-08 | Samyang Biopharmaceuticals Corporation | Polymeric micelle composition containing a poorly soluble drug and preparation method of the same |
-
2015
- 2015-07-28 KR KR1020150106628A patent/KR101787447B1/ko active IP Right Grant
-
2016
- 2016-07-28 JP JP2018504276A patent/JP2018521106A/ja active Pending
- 2016-07-28 EP EP16830852.6A patent/EP3328436A4/en not_active Withdrawn
- 2016-07-28 WO PCT/KR2016/008269 patent/WO2017018819A1/en active Application Filing
- 2016-07-28 CA CA2993923A patent/CA2993923A1/en not_active Abandoned
- 2016-07-28 BR BR112018001719A patent/BR112018001719A2/pt not_active Application Discontinuation
- 2016-07-28 RU RU2018107054A patent/RU2018107054A/ru unknown
- 2016-07-28 MX MX2018001222A patent/MX2018001222A/es unknown
- 2016-07-28 CN CN201680001944.8A patent/CN106659680A/zh active Pending
- 2016-07-28 AU AU2016299547A patent/AU2016299547A1/en not_active Abandoned
-
2018
- 2018-01-28 IL IL257181A patent/IL257181A/en unknown
- 2018-02-21 ZA ZA2018/01186A patent/ZA201801186B/en unknown
- 2018-07-13 HK HK18109125.9A patent/HK1249440A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
ZA201801186B (en) | 2018-12-19 |
KR101787447B1 (ko) | 2017-10-19 |
AU2016299547A1 (en) | 2018-02-22 |
RU2018107054A (ru) | 2019-08-28 |
BR112018001719A2 (pt) | 2018-09-18 |
CN106659680A (zh) | 2017-05-10 |
CA2993923A1 (en) | 2017-02-02 |
WO2017018819A1 (en) | 2017-02-02 |
JP2018521106A (ja) | 2018-08-02 |
KR20170014059A (ko) | 2017-02-08 |
IL257181A (en) | 2018-03-29 |
EP3328436A4 (en) | 2019-03-20 |
EP3328436A1 (en) | 2018-06-06 |
HK1249440A1 (zh) | 2018-11-02 |
RU2018107054A3 (es) | 2019-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY193806A (en) | Affinity-oligonucleotide conjugates and uses thereof | |
EP3130355A4 (en) | Pharmaceutical composition containing pregabalin with improved stability and method for preparing same | |
GEP201706760B (en) | Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same | |
HK1249129A1 (zh) | 用於細胞施予、保存、或培養的容器 | |
MX2016008369A (es) | Composicion farmaceutica que incluye palonosetron. | |
HRP20200104T8 (hr) | Novi heterociklični spoj, metoda za pripremu istog, i farmaceutska kompozicija koja sadrži isto | |
MX2015008588A (es) | Composiciones y metodos para la transfeccion de polinucleótidos. | |
MY188169A (en) | Pharmaceutical compositions and use thereof | |
MX2018001221A (es) | Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla. | |
MX370064B (es) | Preparación de película que contiene donepezilo en su forma de base libre y método para producirla. | |
MX2018001219A (es) | Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla. | |
MX2018001222A (es) | Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla. | |
MX2018001223A (es) | Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla. | |
MX2015010417A (es) | Composicion fungicida. | |
GB2526399B (en) | Battery case for lead-acid battery, lead-acid battery using the battery case, and resin composition for the battery case | |
AU2015901765A0 (en) | Improvements in container base | |
AU2014900972A0 (en) | Method for storing, distributing, enhancing and integrating social media content |